A Study of AC-201 Controlled-Release Tablet (CR Tablet) in Patients With Gout
Clinical trial NCT02287818 · COMPLETED
Trial details
- NCT number
- NCT02287818
- Sponsor
- TWi Biotechnology, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2016-10-27
- Enrollment
- 127
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.